跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
胸腔內科
醫學系
內科學科
電話
+886-2-22490088#2714
電子郵件
[email protected]
網站
http://medschool.tmu.edu.tw/main.php
郵寄地址
在地圖上顯示
概覽
指紋
網路
專家檔案
(18)
專案
(139)
研究成果
(939)
資料集
(46)
指紋
查看啟用 胸腔內科 的研究主題。這些主題標籤來自此機構會員的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor
100%
Lung Cancer
76%
Non Small Cell Lung Cancer
68%
Chronic Obstructive Lung Disease
67%
Mouse
66%
Inflammation
64%
Cohort Study
59%
Asthma
53%
Disease
51%
Lung Adenocarcinoma
49%
Neoplasm
43%
Sleep Disordered Breathing
43%
Malignant Neoplasm
43%
Thrombin
42%
Phosphotransferase
42%
Nuclear Factor
36%
Alternative Complement Pathway C3 C5 Convertase
36%
Connective Tissue Growth Factor
35%
Mycobacterium Tuberculosis
35%
Lung Tuberculosis
34%
Polycyclic Aromatic Hydrocarbon
33%
Cyclooxygenase 2
33%
Multi-Drug-Resistant Tuberculosis
32%
Tuberculostatic Agent
32%
Tumor Necrosis Factor
30%
Interleukin 6
30%
Epidermal Growth Factor Receptor Kinase Inhibitor
26%
Mitogen Activated Protein Kinase
25%
Quinolone Derivative
25%
Tuberculosis
24%
Protein Tyrosine Kinase Inhibitor
24%
Adverse Event
24%
Cytokine
23%
Chemotherapy
23%
Protein Kinase C
23%
Biological Marker
22%
Pleura Effusion
22%
Emphysema
21%
Overall Survival
21%
Randomized Controlled Trial
20%
Cytotoxicity
20%
Infection
20%
Effusion
20%
Plasminogen Activator Inhibitor 1
20%
Diabetes Mellitus
19%
Transforming Growth Factor
19%
Long Term Exposure
19%
Zinc Oxide Nanoparticle
18%
Reactive Oxygen Metabolite
18%
Uridine Triphosphate
18%
Rifampicin
18%
Small Interfering RNA
18%
Carbon Black
17%
Interleukin 8
17%
Coronavirinae
17%
Isoniazid
16%
Fibrosis
16%
Progression Free Survival
16%
Prevalence
16%
Organic Carbon
16%
Lactate Dehydrogenase
16%
Endothelin 1
16%
Cell Viability
16%
Lipopolysaccharide
16%
Chronic Kidney Failure
15%
Ovalbumin
15%
Luciferase
15%
Drug Resistance
15%
SARS Coronavirus
15%
Immunotherapy
14%
Histone Deacetylase Inhibitor
14%
Nitric Oxide
14%
Peptidoglycan
14%
Fibrinogen
14%
Drug Resistant Tuberculosis
14%
Transcription Factor AP 1
12%
Observational Study
12%
Cigarette Smoke
12%
Recurrent Disease
11%
Adenocarcinoma
11%
Western Blot
11%
Normal Human
11%
Adenosine Triphosphate
11%
Inducible Nitric Oxide Synthase
11%
Calcium Ion
10%
Nanoparticle
10%
Lung Disease
10%
Comorbidity
10%
Uvomorulin
10%
Pneumonia
10%
Single Chain Fragment Variable Antibody
10%
Pharmacokinetics
10%
Cardiovascular Disease
10%
Metalloproteinase
10%
Caspase 3
10%
Hypoxia
10%
Sleep Disorder
10%
Gefitinib
9%
Vasculotropin
9%
Respiratory Tract Allergy
9%
Medicine and Dentistry
Lung Cancer
69%
Epidermal Growth Factor Receptor
63%
Cohort Analysis
59%
Chronic Obstructive Pulmonary Disease
59%
Multidrug Resistant Tuberculosis
57%
Lung Tuberculosis
49%
Non Small Cell Lung Cancer
42%
Meta-Analysis
42%
Particular Matter 2.5
38%
Tuberculosis Treatment
32%
Asthma
31%
Disease
31%
Lung Adenocarcinoma
30%
Hazard Ratio
29%
Obstructive Sleep Apnea
28%
Odds Ratio
27%
Infection
26%
Medicine
26%
Atmospheric Aerosol
26%
Diabetes Mellitus
25%
COVID-19
22%
Systematic Review
21%
Chronic Kidney Disease
21%
Pleura Effusion
21%
Neoplasm
21%
Mycobacterium Tuberculosis
20%
Drug Resistant Tuberculosis
20%
Plasminogen Activator Inhibitor-1
19%
Prevalence
19%
Tuberculosis
19%
Tuberculostatic Agent
18%
In Vitro
17%
Overall Survival
17%
Tyrosine-Kinase Inhibitor
16%
Effusion
16%
Severe Acute Respiratory Syndrome Coronavirus 2
16%
Cancer Cell
16%
Rifampicin
16%
Metastatic Carcinoma
16%
Quinolone Derivative
15%
Epidermal Growth Factor Receptor Kinase Inhibitor
15%
Mesothelial Cell
15%
Programmed Cell Death
15%
Intensive Care Unit
15%
Phosphotransferase
15%
Patient-Data
15%
Adverse Event
15%
Observational Study
15%
Tumor Necrosis Factor
14%
Smoking
14%
Polycyclic Aromatic Hydrocarbon
14%
Systemic Lupus Erythematosus
14%
Influenza Vaccination
14%
Malignant Neoplasm
14%
Drug Sensitivity
14%
Diagnosis
13%
Retrospective Cohort Study
12%
Biological Marker
12%
Drug Resistance
12%
Emphysema
11%
4 Iodo 2,5 Dimethoxyamphetamine
11%
Fine Particulate Matter
11%
Progression Free Survival
11%
Symptom
11%
Diabetes
11%
Cytotoxicity
11%
Sepsis
10%
Rheumatoid Arthritis
10%
Non-Small Cell Lung Cancer
10%
Chest Radiograph
10%
Injury
10%
Proportional Hazards Model
10%
Drug Therapy
10%
Macrophage
10%
Extensively Drug Resistant Tuberculosis
9%
Recurrent Disease
9%
Epithelial Cell
9%
Silo-Filler's Disease
9%
Nucleic Acid Amplification
9%
Apoplexy
9%
Surgery
9%
Forced Expiratory Volume
9%
Isoniazid
9%
Malignant Pleural Effusion
9%
Tretinoin
9%
Durvalumab
9%
Pleural Fibrosis
9%
Cytokine
9%
Amino Terminal Sequence
9%
Continuous Positive Airway Pressure
9%
Cancer
9%
Histone Deacetylase Inhibitor
8%
Mitogen-Activated Protein Kinase
8%
Computer Assisted Tomography
8%
Cross Sectional Study
8%
Public Health
8%
Artificial Respiration
8%
Nephrotoxicity
8%
Fibrinogen
8%
Adenocarcinoma
8%
Biochemistry, Genetics and Molecular Biology
Epidermal Growth Factor Receptor
48%
Kinase
39%
Phosphotransferase
38%
Fibroblast
37%
Cohort Study
35%
Connective Tissue Growth Factor
31%
Macrophage
21%
Thrombin
20%
Interleukin 8
18%
K-Complex
18%
Particulate Matter
15%
Breathing
14%
Cancer Cell
14%
Small Interfering RNA
14%
Mycobacterium Tuberculosis
13%
Prevalence
12%
Tyrosine Kinase Inhibitor
12%
Body Mass
12%
Heart Rate Variability
11%
Cyclooxygenase
11%
Promoter Region
11%
down Regulation
10%
Upregulation
10%
Hemodialysis
10%
Platelet
10%
Drug Resistance
10%
Messenger RNA
9%
Signal Transduction
9%
Tretinoin
9%
Luciferase
9%
Smoking
9%
Observational Study
9%
Protein Kinase C
9%
Autophagy
9%
Overall Survival
9%
Immune Checkpoints
9%
Extracellular Signal-Regulated Kinases
9%
N-Terminus
8%
Cell Death
8%
Lipopolysaccharide
8%
Blood Level
8%
Proteomics
8%
Lung Function
8%
AP-1 Transcription Factor
8%
Normal Human
8%
P38 Mitogen-Activated Protein Kinases
8%
Eicosanoid Receptor
8%
Mouse
7%
Oxygen Desaturation
7%
Metalloproteinase
7%
Metalloendopeptidase
7%
Systolic Blood Pressure
7%
Endothelin 1
7%
Transforming Growth Factor
7%
Ccaat-Enhancer-Binding Proteins
7%
Western Blot
7%
Genotyping
7%
Retrospective Study
7%
Blood Pressure
7%
Histone Deacetylase
7%
Disintegrin
7%
Body Water
7%
Peptidoglycan
7%
Agonist
7%
Angiogenesis
6%
Monospecific Antibody
6%
Protein Expression
6%
Gene Expression
6%
Wild Type
6%
Medline
6%
T Cell
6%
C-Reactive Protein
6%
Immunocompetent Cell
6%
Complement Factor B
6%
Leukocyte
6%
Tumor Progression
6%
Oxidative Stress
6%
Survival Rate
6%
Nitric Oxide Synthase
6%
Enzyme
6%
Interleukin-6
6%
P53
5%
Pharmacokinetics
5%
Sulfur Dioxide
5%
Whole Genome Sequencing
5%
Actin
5%
Progression Free Survival
5%
Medical Record
5%
Receptor Tyrosine Kinase Inhibitors
5%
Forced Expiratory Volume
5%
Body Composition
5%
Mitogen-Activated Protein Kinase
5%
Cell Proliferation
5%
STAT3
5%
Droplet Digital Polymerase Chain Reaction
5%
Randomized Controlled Trial
5%
Coagulation System
5%
Diastolic Blood Pressure
5%
Random Forest
5%
Comorbidity
5%